Expression of GLUT-1 Glucose Transporter in Borderline and Malignant Epithelial Tumors of the Ovary

Author： Cantuaria G.   Magalhaes A.   Penalver M.   Angioli R.   Braunschweiger P.   Gomez-Marin O.   Kanhoush R.   Gomez-Fernandez C.   Nadji M.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.79, Iss.1, 2000-10, pp. : 33-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucose Transporter-1 (GLUT-1) Immunoreactivity in Benign, Premalignant and Malignant Lesions of the Gallbladder

By Legan Mateja  

Pathology & Oncology Research, Vol. 17, Iss. 1, 2011-03 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

Borderline epithelial tumors of the ovary: Experience of 55 patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 912-914

Spandidos Publications

Access to resources Recommend Favorite

Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions

By        

Molecular Medicine Reports, Vol. 6, Iss. 3, 2012-01 ,pp. : 601-606

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer

By Cho Hanbyoul   Lee You Sun   Kim Julie   Chung Joon-Yong   Kim Jae-Hoon  

Cancer Investigation, Vol. 31, Iss. 9, 2013-11 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite

CD31 Expression in Benign, Borderline, and Malignant Epithelial Ovarian Tumors: An Immunohistochemical and Serological Analysis

By Darai E.   Bringuier A.-F.   Walker-Combrouze F.   Fauconnier A.   Couvelard A.   Feldmann G.   Madelenat P.   Scoazec J.-Y.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 122-127

Elsevier

Access to resources Recommend Favorite